EXPERIENCE IN USING TENOTEN IN THE TREATMENT OF TICK HYPERKINESIS IN CHILDREN

Abstract

The clinical efficacy of tenoten (pediatric formulation) was comparatively studied in children with tick hyperkinesis. One hundred and thirty children (34 girls and 96 boys) aged 3 to 5 years were examined. The drug of comparison was persen in local ticks and fenibut in generalized ticks. An attempt was also undertaken to treat patients with generalized ticks (Tourette's syndrome), by using tenoten (pediatric formulation). As shown by the results of the study, tenoten (pediatric formulation) is most effective in local ticks. In generalized hyperkinesis, tenoten is as effective as fenibut and the former is, in some cases, superior to the latter. Monotherapy with tenoten (pediatric formulation) is insufficiently effective in Tourette's syndrome. Tenoten (pediatric formulation) has been also shown to diminish anxiety and to have a positive effect on the biological activity of the brain. The agent is safe and there have been no adverse reactions due to its use.